REFERENCES

1. Arterburn D, Wellman R, Emiliano A, et al. ; PCORnet Bariatric Study Collaborative. Comparative effectiveness and safety of bariatric procedures for weight loss: a PCORnet cohort study. Ann Intern Med. 2018;169:741-50.

2. El Ansari W, Elhag W. Weight regain and insufficient weight loss after bariatric surgery: definitions, prevalence, mechanisms, predictors, prevention and management strategies, and knowledge Gaps-a scoping review. Obes Surg. 2021;31:1755-66.

3. Ataya K, Al Jaafreh AM, El Bourji H, et al. Roux-en-Y gastric bypass versus one anastomosis gastric bypass as revisional surgery after failed sleeve gastrectomy: a systematic review and meta-analysis. J Metab Bariatr Surg. 2023;12:57-66.

4. Stanley C, Mallik R, Hamid N, et al. Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial. Nat Med. 2026;32:2662-72.

5. Wilding JPH, Batterham RL, Calanna S, et al. ; STEP 1 Study Group. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989-1002.

6. King WC, Hinerman AS, Belle SH, Wahed AS, Courcoulas AP. Comparison of the performance of common measures of weight regain after bariatric surgery for association with clinical outcomes. JAMA. 2018;320:1560-9.

7. Laurino Neto RM, Herbella FA, Tauil RM, Silva FS, de Lima SE Jr. Comorbidities remission after Roux-en-Y gastric bypass for morbid obesity is sustained in a long-term follow-up and correlates with weight regain. Obes Surg. 2012;22:1580-5.

8. de Moraes FCA, Morbach V, Sano VKT, Fernandes LR, Kreuz M, Kelly FA. Liraglutide for the treatment of weight regain after bariatric surgery: a systematic review and meta-analysis. Obes Surg. 2024;34:2844-53.

9. Jamal M, Alhashemi M, Dsouza C, et al. Semaglutide and tirzepatide for the management of weight recurrence after sleeve gastrectomy: a retrospective cohort study. Obes Surg. 2024;34:1324-32.

10. Ndumele CE, Rodriguez F, Dixon DL, et al. 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2026;87:e1889-2007.